Benzinga | Jan 5, 2022 07:11AM EST

B of A Securities Upgrades Pfizer to Buy, Raises Price Target to $70

B of A Securities analyst Geoff Meacham upgrades Pfizer (NYSE:PFE) from Neutral to Buy and raises the price target from $59 to $70.